Beach Investment Counsel Inc. PA trimmed its stake in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 17.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,560 shares of the company's stock after selling 12,380 shares during the period. Beach Investment Counsel Inc. PA's holdings in Roche were worth $2,008,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of RHHBY. Verity Asset Management Inc. boosted its stake in Roche by 26.8% during the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after purchasing an additional 1,697 shares during the last quarter. Hantz Financial Services Inc. boosted its position in Roche by 0.9% during the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock worth $1,176,000 after acquiring an additional 305 shares during the last quarter. Brooklyn Investment Group grew its stake in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock valued at $48,000 after acquiring an additional 363 shares in the last quarter. Diversified Trust Co lifted its position in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company's stock worth $2,130,000 after buying an additional 711 shares in the last quarter. Finally, Bard Financial Services Inc. boosted its stake in Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company's stock worth $3,866,000 after buying an additional 30,350 shares during the last quarter.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein raised shares of Roche to a "strong-buy" rating in a research note on Thursday, January 30th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating, one has assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold".
Check Out Our Latest Stock Analysis on RHHBY
Roche Trading Down 2.3 %
Shares of OTCMKTS RHHBY traded down $0.92 during mid-day trading on Friday, reaching $39.61. 1,597,055 shares of the company's stock were exchanged, compared to its average volume of 1,837,004. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43. The company's 50-day moving average is $36.55 and its 200-day moving average is $38.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Stories
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
